Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee

ConclusionsBiopathology findings from this study support the different prognosis of infantile RMS. New fusion ‐positive SRMS has a very good outcome which may allow more conservative treatment in the future.

Source: Cancer Medicine - February 25, 2020 Category: Cancer & Oncology Authors: Thibault Butel, Marie Karanian, Gaelle Pierron, Daniel Orbach, Dominique Ranchere, Nathalie Cozic, Louise Galmiche, Aurore Coulomb, Nad ège Corradini, Brigitte Lacour, Stéphanie Proust, Florent Guerin, Hélène Boutroux, Angélique Rome, L Tags: ORIGINAL RESEARCH Source Type: research